Stay Informed
Stay Ahead of the Science
Weekly insights on GLP-1, NAD+, peptide protocols, and mitochondrial health — curated by our scientific team and delivered straight to your inbox.
No spam. Unsubscribe anytime.
Join 2,500+ researchers
What You’ll Receive
Clinical Study Summaries
Stay updated on the latest peer-reviewed research in GLP-1, NAD+, and metabolic health — distilled for clarity.
Exclusive Whitepapers
Access in-depth technical reports, mechanism deep-dives, and data releases not available on the public blog.
Peptide & Compound Insights
Learn about new peptide protocols, NAD+ precursors, and GLP-1 analogs before they hit the mainstream.
Longevity Breakthroughs
Curated updates on mitochondrial dynamics, sirtuin activation, and the science of healthy aging.
Recent Updates
Here’s a glimpse of what subscribers received recently:
Clinical Study
NAD+ IV Therapy: Meta-Analysis of Neurological Outcomes
Jun 20, 2026
Peptide
Synergistic Effects of BPC-157 & TB-500 in Tissue Repair
Jun 14, 2026
GLP-1
Tirzepatide vs. Semaglutide: Comparative Metabolic Profiles
Jun 7, 2026
Longevity
Mitochondrial Dynamics in Aging: A Cellular Perspective
May 30, 2026
🌱 Where GLP-1 Science, Peptides & Longevity Converge
glp1cynergy.com
📬 Contact:
researchhub@glp1cynergy.com